GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Cyclically Adjusted FCF per Share

Corline Biomedical AB (OSTO:CLBIO) Cyclically Adjusted FCF per Share : kr-0.95 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Corline Biomedical AB's adjusted free cash flow per share for the three months ended in Mar. 2024 was kr0.021. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.95 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-04), Corline Biomedical AB's current stock price is kr10.95. Corline Biomedical AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr-0.95. Corline Biomedical AB's Cyclically Adjusted Price-to-FCF of today is .


Corline Biomedical AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Corline Biomedical AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Cyclically Adjusted FCF per Share Chart

Corline Biomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Corline Biomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.95

Competitive Comparison of Corline Biomedical AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Corline Biomedical AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Cyclically Adjusted Price-to-FCF falls into.



Corline Biomedical AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corline Biomedical AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.021/132.2054*132.2054
=0.021

Current CPI (Mar. 2024) = 132.2054.

Corline Biomedical AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.000 100.541 0.000
201406 -0.175 100.432 -0.230
201409 -0.155 100.161 -0.205
201412 -0.022 100.225 -0.029
201503 -0.191 99.950 -0.253
201506 -0.232 99.995 -0.307
201509 -0.224 100.228 -0.295
201512 -0.300 100.276 -0.396
201603 -0.356 100.751 -0.467
201606 -0.248 101.019 -0.325
201609 -0.338 101.138 -0.442
201612 -0.362 102.022 -0.469
201703 0.328 102.022 0.425
201706 -0.360 102.752 -0.463
201709 -0.294 103.279 -0.376
201712 -0.378 103.793 -0.481
201803 -0.344 103.962 -0.437
201806 -0.205 104.875 -0.258
201809 0.394 105.679 0.493
201812 -0.196 105.912 -0.245
201903 -0.299 105.886 -0.373
201906 -0.231 106.742 -0.286
201909 -0.301 107.214 -0.371
201912 -0.285 107.766 -0.350
202003 -0.359 106.563 -0.445
202006 -0.266 107.498 -0.327
202009 -0.275 107.635 -0.338
202012 0.069 108.296 0.084
202103 -0.246 108.360 -0.300
202106 -0.193 108.928 -0.234
202109 -0.222 110.338 -0.266
202112 -0.059 112.486 -0.069
202203 -0.282 114.825 -0.325
202206 -0.150 118.384 -0.168
202209 -0.169 122.296 -0.183
202212 -0.119 126.365 -0.124
202303 -0.296 127.042 -0.308
202306 0.043 129.407 0.044
202309 -0.200 130.224 -0.203
202403 0.021 132.205 0.021

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Corline Biomedical AB  (OSTO:CLBIO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Corline Biomedical AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Corline Biomedical AB (OSTO:CLBIO) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines